Literature DB >> 9832043

Juvenile rheumatoid arthritis and del(22q11) syndrome: a non-random association.

A Verloes1, C Curry, M Jamar, C Herens, P O'Lague, J Marks, P Sarda, P Blanchet.   

Abstract

Del(22q11) is a common microdeletion syndrome with an extremely variable phenotype. Besides classical manifestations, such as velocardiofacial (Shprintzen) or DiGeorge syndromes, del(22q11) syndrome may be associated with unusual but probably causally related anomalies that expand its phenotype and complicate its recognition. We report here three children with the deletion and a chronic, erosive polyarthritis resembling idiopathic cases of juvenile rheumatoid arthritis (JRA). Patient 1, born in 1983, initially presented with developmental delay, facial dysmorphism, velopharyngeal insufficiency, and severe gastro-oesophageal reflux requiring G tube feeding. From the age of 3 years, he developed JRA, which resulted in severe restrictive joint disease, osteopenia, and platyspondyly. Patient 2, born in 1976, had tetralogy of Fallot and peripheral pulmonary artery stenosis. She developed slowly, had mild dysmorphic facial features, an abnormal voice, and borderline intelligence. JRA was diagnosed at the age of 5 years. The disorder followed a subacute course, with relatively mild inflammatory phenomena, but an extremely severe skeletal involvement with major osteopenia, restrictive joint disease (bilateral hip replacement), and almost complete osteolysis of the carpal and tarsal bones with phalangeal synostoses, leading to major motor impairment and confinement to a wheelchair. Patient 3, born in 1990, has VSD, right embryo-toxon, bifid uvula, and facial dysmorphism. She developed JRA at the age of 1 year. She is not mentally retarded but has major speech delay secondary to congenital deafness inherited from her mother. In the three patients, a del(22q11) was shown by FISH analysis. These observations, and five other recently published cases, indicate that a JRA-like syndrome is a component of the del(22q11) spectrum. The deletion may be overlooked in those children with severe, chronic inflammatory disorder.

Entities:  

Mesh:

Year:  1998        PMID: 9832043      PMCID: PMC1051489          DOI: 10.1136/jmg.35.11.943

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  31 in total

Review 1.  Immune abnormalities in the pathogenesis of juvenile rheumatoid arthritis.

Authors:  R N Lipnick; G C Tsokos
Journal:  Clin Exp Rheumatol       Date:  1990 Mar-Apr       Impact factor: 4.473

2.  Di George anomaly and velocardiofacial syndrome.

Authors:  C A Stevens; J C Carey; A O Shigeoka
Journal:  Pediatrics       Date:  1990-04       Impact factor: 7.124

3.  The DiGeorge sequence. II. Immunologic findings in partial and complete forms of the disorder.

Authors:  W Müller; H H Peter; H C Kallfelz; A Franz; C H Rieger
Journal:  Eur J Pediatr       Date:  1989-11       Impact factor: 3.183

4.  DiGeorge syndrome: long-term survival complicated by Graves disease.

Authors:  A J Ham Pong; A Cavallo; G H Holman; A S Goldman
Journal:  J Pediatr       Date:  1985-04       Impact factor: 4.406

Review 5.  Velo-cardio-facial syndrome: a review of 120 patients.

Authors:  R Goldberg; B Motzkin; R Marion; P J Scambler; R J Shprintzen
Journal:  Am J Med Genet       Date:  1993-02-01

6.  Confirmation that the velo-cardio-facial syndrome is associated with haplo-insufficiency of genes at chromosome 22q11.

Authors:  D Kelly; R Goldberg; D Wilson; E Lindsay; A Carey; J Goodship; J Burn; I Cross; R J Shprintzen; P J Scambler
Journal:  Am J Med Genet       Date:  1993-02-01

7.  Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus.

Authors:  P J Scambler; D Kelly; E Lindsay; R Williamson; R Goldberg; R Shprintzen; D I Wilson; J A Goodship; I E Cross; J Burn
Journal:  Lancet       Date:  1992-05-09       Impact factor: 79.321

8.  A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analysed in 30 patients.

Authors:  A M Prieur; C Griscelli; F Lampert; H Truckenbrodt; M A Guggenheim; D J Lovell; P Pelkonnen; J Chevrant-Breton; B M Ansell
Journal:  Scand J Rheumatol Suppl       Date:  1987

9.  Isolation of a gene expressed during early embryogenesis from the region of 22q11 commonly deleted in DiGeorge syndrome.

Authors:  S Halford; D I Wilson; S C Daw; C Roberts; R Wadey; S Kamath; A Wickremasinghe; J Burn; J Goodship; M G Mattei
Journal:  Hum Mol Genet       Date:  1993-10       Impact factor: 6.150

10.  Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study.

Authors:  A K Ryan; J A Goodship; D I Wilson; N Philip; A Levy; H Seidel; S Schuffenhauer; H Oechsler; B Belohradsky; M Prieur; A Aurias; F L Raymond; J Clayton-Smith; E Hatchwell; C McKeown; F A Beemer; B Dallapiccola; G Novelli; J A Hurst; J Ignatius; A J Green; R M Winter; L Brueton; K Brøndum-Nielsen; P J Scambler
Journal:  J Med Genet       Date:  1997-10       Impact factor: 6.318

View more
  6 in total

1.  Autoimmune hyperthyroidism in two adolescents with DiGeorge/velocardiofacial syndrome (22q11 deletion).

Authors:  Maria Segni; Donald Zimmerman
Journal:  Eur J Pediatr       Date:  2002-04       Impact factor: 3.183

Review 2.  Immunological aspects of 22q11.2 deletion syndrome.

Authors:  A R Gennery
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

3.  Uveitis in DiGeorge syndrome: a case of autoimmune ocular inflammation in a patient with deletion 22q11.2.

Authors:  Chloe Gottlieb; Zhuqing Li; Gulbu Uzel; Robert B Nussenblatt; H Nida Sen
Journal:  Ophthalmic Genet       Date:  2010-03       Impact factor: 1.803

4.  A case of juvenile idiopathic polyarticular arthritis complicated by IgA deficiency in 22q11 deletion syndrome.

Authors:  Satoshi Sato; Hisashi Kawashima; Kazunori Suzuki; Ryuhei Nagao; Kazumitsu Tsuyuki; Akinori Hoshika
Journal:  Rheumatol Int       Date:  2009-12-11       Impact factor: 2.631

5.  Association of juvenile idiopathic arthritis and digeorge syndrome; a case report.

Authors:  Farhad Salehzadeh; Amin Bagheri
Journal:  Iran J Pediatr       Date:  2014-06       Impact factor: 0.364

Review 6.  Immunodeficiency in DiGeorge Syndrome and Options for Treating Cases with Complete Athymia.

Authors:  E Graham Davies
Journal:  Front Immunol       Date:  2013-10-31       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.